CLD
Advancing Biologics Development With Next-Generation Cell Line Development
Woo Chi, Ph.D.; Yingji Jin, Ph.D.; Jaeeun Kim
Samsung Biologics
PAO-06-25-CL-06Jun 16, 2025
CDMO
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
Samsung Biologics
PR-10-24-NI-41Oct 14, 2024
Bioassays
Developing a Toolbox of Functional Bioassays for Optimizing ADCC
Anke Hartung, Ph.D.,
Tanvex CDMO
PAO-09-24-CL-09Sep 30, 2024